Oncology

Roche in Cancer Care

The Roche Group is the world's leading provider of cancer care products. Our anti-cancer medicines are saving lives and significantly advancing the way some cancers are treated. In addition, Roche is developing new diagnostic tests that will have a significant impact on disease management for cancer patients in the future. With a broad portfolio of tumour markers as well as a range of molecular oncology tests, Roche will continue to be one of the leaders in providing cancer-focused treatments and diagnostics.

Attached media for this topic

Disease Backgrounders

TitleType
Epidemiology of cancerPDF
Breast cancer PDF
Stomach cancer PDF
Chronic Lymphocytic LeukemiaPDF
Colorectal cancer PDF
Non-Hodgkin's Lymphoma PDF
Non Small Cell Lung cancer PDF
HER2-positive cancerPDF
Skin cancer (Melanoma) PDF
Ovarian cancerPDF
GlioblastomaPDF
Advanced Basal Cell CarcinomaPDF
Info graphic
Cervical cancerPDF
GlioblastomaPDF
Lung cancerPDF
Stages of Breast cancerPDF
HER2-positive breast cancerPDF
Colorectal cancerPDF
Non Hodgkins LymphomaPDF
Chronic lymphocytic leukemiaPDF
Advanced Basal Cell CarcinomaPDF
Advanced breast cancerPDF
Antibody drug conjugates (ADCs)PDF
KNOW MORE: Breast cancerPDF
Breast CancerPDF
Video
Avastin ProductionZIP